290 related articles for article (PubMed ID: 24396042)
1. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
2. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
3. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
4. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei.
Wang ML; Feng YH; Pang W; Qi ZM; Zhang Y; Guo YJ; Luo EJ; Cao YM
Malar J; 2014 Mar; 13():116. PubMed ID: 24670210
[TBL] [Abstract][Full Text] [Related]
5. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Burrack KS; Huggins MA; Taras E; Dougherty P; Henzler CM; Yang R; Alter S; Jeng EK; Wong HC; Felices M; Cichocki F; Miller JS; Hart GT; Johnson AJ; Jameson SC; Hamilton SE
Immunity; 2018 Apr; 48(4):760-772.e4. PubMed ID: 29625893
[TBL] [Abstract][Full Text] [Related]
7. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
Lv Y; Wu S; Nie Q; Liu S; Xu W; Chen G; Du Y; Chen J
Int Immunopharmacol; 2024 May; 132():111982. PubMed ID: 38569430
[TBL] [Abstract][Full Text] [Related]
10. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
12. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice.
Wang ML; Cao YM; Luo EJ; Zhang Y; Guo YJ
Malar J; 2013 Sep; 12():322. PubMed ID: 24034228
[TBL] [Abstract][Full Text] [Related]
13. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
Kuehlwein JM; Borsche M; Korir PJ; Risch F; Mueller AK; Hübner MP; Hildner K; Hoerauf A; Dunay IR; Schumak B
Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-10 in inhibiting protective immune responses against infection with heterologous Plasmodium parasites.
Nakamae S; Kimura D; Miyakoda M; Sukhbaatar O; Inoue SI; Yui K
Parasitol Int; 2019 Jun; 70():5-15. PubMed ID: 30639137
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.
Schmidt KE; Kuepper JM; Schumak B; Alferink J; Hofmann A; Howland SW; Rénia L; Limmer A; Specht S; Hoerauf A
PLoS One; 2018; 13(2):e0192717. PubMed ID: 29438386
[TBL] [Abstract][Full Text] [Related]
16. Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites.
Gerald NJ; Majam V; Mahajan B; Kozakai Y; Kumar S
PLoS One; 2011; 6(9):e24398. PubMed ID: 21935405
[TBL] [Abstract][Full Text] [Related]
17. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
19. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
[TBL] [Abstract][Full Text] [Related]
20. Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice.
Lee DH; Chu KB; Kang HJ; Lee SH; Quan FS
Korean J Parasitol; 2019 Apr; 57(2):93-99. PubMed ID: 31104401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
